Advertisement
IBM or JNJ or LIN
| IBM | JNJ | LIN | |
| Capitalization | 216B | 651B | 212B |
| EBITDA | 17.6B | 34B | 13.6B |
| Gain YTD | -20.926 | 32.560 | 9.039 |
| P/E Ratio | 20.39 | 31.32 | 29.70 |
| Revenue | 69.1B | 97.9B | 35.4B |
| Total Cash | 8.13B | 20.8B | 4.9B |
| Total Debt | 65.3B | 49B | 28B |
IBM | JNJ | LIN | ||
|---|---|---|---|---|
OUTLOOK RATING 1..100 | 93 | 81 | 50 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 9 Undervalued | 12 Undervalued | 75 Overvalued | |
PROFIT vs RISK RATING 1..100 | 48 | 5 | 24 | |
SMR RATING 1..100 | 29 | 37 | 48 | |
PRICE GROWTH RATING 1..100 | 59 | 40 | 59 | |
P/E GROWTH RATING 1..100 | 93 | 10 | 56 | |
SEASONALITY SCORE 1..100 | 50 | 50 | 65 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
IBM's Valuation (9) in the Information Technology Services industry is in the same range as JNJ (12) in the Pharmaceuticals Major industry, and is significantly better than the same rating for LIN (75) in the Chemicals Specialty industry. This means that IBM's stock grew similarly to JNJ’s and significantly faster than LIN’s over the last 12 months.
JNJ's Profit vs Risk Rating (5) in the Pharmaceuticals Major industry is in the same range as LIN (24) in the Chemicals Specialty industry, and is somewhat better than the same rating for IBM (48) in the Information Technology Services industry. This means that JNJ's stock grew similarly to LIN’s and somewhat faster than IBM’s over the last 12 months.
IBM's SMR Rating (29) in the Information Technology Services industry is in the same range as JNJ (37) in the Pharmaceuticals Major industry, and is in the same range as LIN (48) in the Chemicals Specialty industry. This means that IBM's stock grew similarly to JNJ’s and similarly to LIN’s over the last 12 months.
JNJ's Price Growth Rating (40) in the Pharmaceuticals Major industry is in the same range as IBM (59) in the Information Technology Services industry, and is in the same range as LIN (59) in the Chemicals Specialty industry. This means that JNJ's stock grew similarly to IBM’s and similarly to LIN’s over the last 12 months.
JNJ's P/E Growth Rating (10) in the Pharmaceuticals Major industry is somewhat better than the same rating for LIN (56) in the Chemicals Specialty industry, and is significantly better than the same rating for IBM (93) in the Information Technology Services industry. This means that JNJ's stock grew somewhat faster than LIN’s and significantly faster than IBM’s over the last 12 months.
| IBM | JNJ | LIN | |
|---|---|---|---|
| RSI ODDS (%) | N/A | 3 days ago 42% | 3 days ago 44% |
| Stochastic ODDS (%) | 3 days ago 66% | 3 days ago 52% | 3 days ago 51% |
| Momentum ODDS (%) | 3 days ago 62% | 3 days ago 45% | 3 days ago 39% |
| MACD ODDS (%) | 3 days ago 68% | 3 days ago 36% | 3 days ago 42% |
| TrendWeek ODDS (%) | 3 days ago 56% | 3 days ago 47% | 3 days ago 45% |
| TrendMonth ODDS (%) | 3 days ago 52% | 3 days ago 51% | 3 days ago 50% |
| Advances ODDS (%) | 7 days ago 66% | 4 days ago 47% | 21 days ago 48% |
| Declines ODDS (%) | 5 days ago 55% | 10 days ago 40% | 4 days ago 45% |
| BollingerBands ODDS (%) | 3 days ago 45% | 3 days ago 42% | 3 days ago 47% |
| Aroon ODDS (%) | 3 days ago 62% | 3 days ago 49% | 3 days ago 46% |
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
IBM’s FA Score shows that 2 FA rating(s) are green while JNJ’s FA Score has 3 green FA rating(s), and LIN’s FA Score reflects 1 green FA rating(s).
- IBM’s FA Score: 2 green, 3 red.
- JNJ’s FA Score: 3 green, 2 red.
- LIN’s FA Score: 1 green, 4 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
IBM’s TA Score shows that 4 TA indicator(s) are bullish while JNJ’s TA Score has 3 bullish TA indicator(s), and LIN’s TA Score reflects 4 bullish TA indicator(s).
- IBM’s TA Score: 4 bullish, 5 bearish.
- JNJ’s TA Score: 3 bullish, 5 bearish.
- LIN’s TA Score: 4 bullish, 4 bearish.
Price Growth
IBM (@Information Technology Services) experienced а -5.65% price change this week, while JNJ (@Pharmaceuticals: Major) price change was +1.66% , and LIN (@Chemicals: Specialty) price fluctuated -1.25% for the same time period.
The average weekly price growth across all stocks in the @Information Technology Services industry was +2.49%. For the same industry, the average monthly price growth was +6.80%, and the average quarterly price growth was +22.01%.
The average weekly price growth across all stocks in the @Pharmaceuticals: Major industry was +1.82%. For the same industry, the average monthly price growth was -6.21%, and the average quarterly price growth was +15.37%.
The average weekly price growth across all stocks in the @Chemicals: Specialty industry was -0.41%. For the same industry, the average monthly price growth was -4.61%, and the average quarterly price growth was +10.73%.
Reported Earning Dates
IBM is expected to report earnings on Oct 21, 2026.
JNJ is expected to report earnings on Oct 20, 2026.
LIN is expected to report earnings on Oct 22, 2026.
Industries' Descriptions
@Information Technology Services (+2.49% weekly)The industry, whose total market cap runs into trillions, makes hardware/software that allows data to be stored, retrieved, transmitted, and manipulated on computers. With the ever-increasing relevance of data, the information technology (IT) industry has gained momentous growth over the years, and continues to thrive on innovation. Some of the behemoths in the industry are International Business Machines Corporation, Accenture, and VMware, Inc.
@Pharmaceuticals: Major (+1.82% weekly)The Major Pharmaceuticals industry includes companies that are involved in various processes of creating drugs to treat/prevent diseases. These companies engage in research, testing and manufacturing, as well as the distribution of pharmaceuticals into markets. Johnson & Johnson, Merck & Co., Inc., Pfizer Inc. and Novartis are among the largest companies in this category.
@Chemicals: Specialty (-0.41% weekly)The specialty chemicals sector includes companies that produce chemicals and industrial gases, which are of relatively high-value, often made to customer specifications. Examples of specialty chemicals are electronic chemicals, industrial gases, coatings, adhesives and sealants, industrial and institutional cleaning chemicals. The products are often valued on the basis of their purposes/performances rather than for their composition. Linde Plc, Ecolab Inc., Air Products and Chemicals, Inc., and Dow, Inc. are some of the largest companies making specialty chemicals.
Advertisement
IBM and
Correlation & Price change
A.I.dvisor indicates that over the last year, IBM has been loosely correlated with DXC. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if IBM jumps, then DXC could also see price increases.
| Ticker / NAME | Correlation To IBM | 1D Price Change % | ||
|---|---|---|---|---|
| IBM | 100% | -3.45% | ||
| DXC - IBM | 48% Loosely correlated | -5.77% | ||
| CTSH - IBM | 46% Loosely correlated | -3.25% | ||
| GIB - IBM | 46% Loosely correlated | -2.50% | ||
| HCKT - IBM | 45% Loosely correlated | -2.63% | ||
| ACN - IBM | 44% Loosely correlated | -4.73% | ||
More | ||||